+43 316 269 205 office@innophore.com

ABOUT US

VISION

 

The R&D vision of Innophore is to identify high-value industrial and therapeutic enzymes and to develop and identify enzymes for more efficient, green chemical production processes and novel biosimilars for medical treatments.

Furthermore, we strive to make important contributions to the re-purposing of drugs as well as the prediction of drug side effects with the help of our 3D point cloud technology.

team1
team2

TEAM

Dr. Christian Gruber

Dr. Christian Gruber

CEO

Dr. Georg Steinkellner

Dr. Georg Steinkellner

CTO

Prof. Karl Gruber

Prof. Karl Gruber

CSO

Christoph Blaschitz, MSc.

Christoph Blaschitz, MSc.

CFO

Dr. Mario Müller

Dr. Mario Müller

Research Manager and coordinator

Dr. Vedat Durmaz

Dr. Vedat Durmaz

Senior Data Scientist

PD Dr. Andreas Krassnigg

PD Dr. Andreas Krassnigg

Senior AI Strategist/Developer

Dr. Marco Cespugli

Dr. Marco Cespugli

Structural Bioinformatician

PD Dr. Bettina Nestl

PD Dr. Bettina Nestl

Senior Scientist / Key Account Management

Ursula Kahler, MSc.

Ursula Kahler, MSc.

Scientist

Alexander Korsunsky, MSc.

Alexander Korsunsky, MSc.

Scientific Software Developer

Michael Hetmann, MSc

Michael Hetmann, MSc

Structural Bioinformatician

Amela Kurtić, BSc.

Amela Kurtić, BSc.

Full-Stack Developer

Daniel Nutz

Daniel Nutz

Data Scientist

Klara Blaschitz

Klara Blaschitz

Researcher

Katharina Köchl, Bsc

Katharina Köchl, Bsc

Master Student

Centina König

Centina König

Programmer

Mag. Sabrina Krammer, MBA

Mag. Sabrina Krammer, MBA

Funding

Mag. Hanna Lindermuth

Mag. Hanna Lindermuth

Technical writing and grant coordination support

Alice Guarneri, MSc

Alice Guarneri, MSc

PhD Student, ESR/PBC

Innophore GmbH is a spin-off company of acib GmbH and University of Graz and was supported as founding project by Science Park Graz GmbH in the framework of the AplusB program.

Innophore GmbH is supported by the strategic investor EOSS Industries GmbH.